GlassScriptPhysician profile
Donna L Spence
NPI 1578569950
$1,103.68
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $945 · 2022: $102 · 2023: $25.15 · 2024: $31.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $56.37.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $56.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $171.22 | 2021 | |
| Amarin Pharma, INC. | $108.78 | 2021 | |
| Novo Nordisk INC | $97.22 | 2021-2022 | |
| Lilly USA, LLC | $81.23 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $77.73 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $65.88 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.72 | 2021-2022 | |
| Insulet Corporation | $52.53 | 2021 | |
| Glaxosmithkline, LLC. | $49.83 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $49.50 | 2021 | |
| Dexcom, INC. | $41.04 | 2021-2023 | Dexcom G6 Transmitter |
| Genentech USA, INC. | $40.53 | 2021 | |
| Boston Scientific Corporation | $31.22 | 2024 | Wavewriter Alpha Prime 16 |
| Upsher-Smith Laboratories LLC | $21.96 | 2021 | |
| Abbott Laboratories | $21.20 | 2022 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biohaven Pharmaceutical Holding Company LTD. | $19.14 | 2022 | |
| Currax Pharmaceuticals LLC | $17.79 | 2021 | |
| Supernus Pharmaceuticals, INC. | $15.96 | 2021 | |
| Horizon Therapeutics Plc | $14.80 | 2021 | |
| Eisai INC. | $14.64 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.40 | 2021 | |
| Mylan Specialty L.P. | $12.20 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $11.10 | 2021 | |
| Pfizer INC. | $11.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Donna Spence listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.